Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Press Release/Announcement

Request for comments on the proposed measures and 2020 targets for the National Action Plan for Adverse Drug Event Prevention: inpatient and outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics.

Office of Disease Prevention and Health Promotion, US Department of Health and Human Services. Fed Register. October 20, 2016;81:72594-72595.

Save
Print
November 2, 2016
Office of Disease Prevention and Health Promotion, US Department of Health and Human Services. Fed Register. October 20, 2016;81:72594-72595.

National attention has focused on efforts to address adverse drug events. This call for comments seeks insights regarding revisions to a 2014 action plan that highlighted how to reduce adverse drug events associated with anticoagulants, diabetes agents, and opioids. These proposed updates involve measures to apply in both the inpatient and outpatient environments to track adverse drug events. The opportunity to submit written comments is now closed.

Save
Print
Cite
Citation

Office of Disease Prevention and Health Promotion, US Department of Health and Human Services. Fed Register. October 20, 2016;81:72594-72595.

Related Resources From the Same Author(s)
Related Resources